Big Rock Partners Acquisition Corp., a special purpose acquisition company, has entered into a merger agreement valued at $500 million with NeuroRx. NeuroRx, which is based in Wilmington and has its operational headquarters in Radnor, is a clinical-stage pharmaceutical company developing treatments for Covid-19 and bipolar depression. The company also has operations in Israel. Under […]

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel, “off the shelf” cell therapies for unmet medical needs. Lineage’s programs are based on its proprietary cell therapy platform and in-house development and manufacturing capabilities. Their lead program features the manufacture and transplant of retinal pigment epithelium cells for the treatment of dry age-related macular degeneration, […]

How the pandemic’s impact on physicians and patients has spurred fundamental changes and redefined approaches in areas such as adherence and drug formulation and delivery. According to the Commonwealth Fund, the number of visits to ambulatory practices declined nearly 60% by early April. Though a rebound was felt by mid-May, the number of visits was […]